COMMUNIQUÉS West-GlobeNewswire

argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025
19/08/2025
August 19, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it [...]
Idorsia publishes end results of repurchase offer for its 2025 and 2028 convertible bonds
19/08/2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August 19, 2025 Idorsia Ltd (SIX: IDIA) announces the end results of the repurchase offer for its outstanding CHF 204 * million convertible bonds [...]
CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program
19/08/2025
SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary [...]
Sienna Announces Offering of $175 Million of 4.112% Series E Senior Unsecured Debentures and Closing of Previously Announced Acquisition in Greater Toronto Area
19/08/2025
NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) [...]
Opthea Provides Corporate Update
19/08/2025
Successful DFA settlement reached Company with cash and cash equivalents of approximately USD20M Dr Fred Guerard, CEO, Tom Reilly, CFO, and Sujal Shah, Director, to step down Dr Jeremy Levin to continue as Chairman and [...]
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
18/08/2025
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced that its Founder and CEO, Dr. Ryan Saadi, has donated 10,000 of his personal shares of [...]
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
18/08/2025
WARREN, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced that Founder and CEO of Tevogen, Dr. Ryan Saadi, donated 10,000 of his personal shares [...]
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2025
CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, between August 4, 2025, and [...]
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
18/08/2025
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA ® (pemivibart) against XFG Centers for Disease Control data and wastewater surveillance data indicate XFG variant appears to [...]
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
18/08/2025
WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) [...]
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
18/08/2025
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical [...]
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
18/08/2025
First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Iovance [...]
Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
18/08/2025
GARDNER, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Nyxoah Reports Second Quarter Financial and Operating Results
18/08/2025
REGULATED INFORMATION Nyxoah Reports Second Quarter Financial and Operating Results FDA Approves Genio® System for U.S. Market; Company Begins Commercial Launch Mont-Saint-Guibert, Belgium – August 18, 2025, 10:10pm CET [...]
Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025
18/08/2025
INFORMATIONS RÉGLEMENTÉES Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025 La FDA approuve le système Genio® pour le marché américain ; la Société lance la commercialisation du [...]
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
18/08/2025
BRISBANE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
18/08/2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
18/08/2025
Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, N.Y., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based [...]
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
18/08/2025
WATERTOWN, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]

Pages